|
1
|
Chou CT, Yang JS and Lee MR: Apoptosis in
rheumatoid arthritis - expression of Fas, Fas-L, p53, and Bcl-2 in
rheumatoid synovial tissues. J Pathol. 193:110–116. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Tak PP, Zvaifler NJ, Green DR and
Firestein GS: Rheumatoid arthritis and p53: How oxidative stress
might alter the course of inflammatory diseases. Immunol Today.
21:78–82. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Yamanishi Y, Boyle DL, Rosengren S, Green
DR, Zvaifler NJ and Firestein GS: Regional analysis of p53
mutations in rheumatoid arthritis synovium. Proc Natl Acad Sci USA.
99:10025–10030. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Alamanos Y and Drosos AA: Epidemiology of
adult rheumatoid arthritis. Autoimmun Rev. 4:130–136. 2005.
View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Zhu P, Lu N, Shi ZG, Zhou J, Wu ZB, Yang
Y, Ding J and Chen ZN: CD147 overexpression on synoviocytes in
rheumatoid arthritis enhances matrix metalloproteinase production
and invasiveness of synoviocytes. Arthritis Res Ther. 8:R442006.
View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Hayashi S, Miura Y, Nishiyama T, Mitani M,
Tateishi K, Sakai Y, Hashiramoto A, Kurosaka M, Shiozawa S and
Doita M: Decoy receptor 3 expressed in rheumatoid synovial
fibroblasts protects the cells against Fas-induced apoptosis.
Arthritis Rheum. 56:1067–1075. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Pitti RM, Marsters SA, Lawrence DA, Roy M,
Kischkel FC, Dowd P, Huang A, Donahue CJ, Sherwood SW, Baldwin DT,
et al: Genomic amplification of a decoy receptor for Fas ligand in
lung and colon cancer. Nature. 396:699–703. 1998. View Article : Google Scholar
|
|
8
|
Bai C, Connolly B, Metzker ML, Hilliard
CA, Liu X, Sandig V, Soderman A, Galloway SM, Liu Q, Austin CP and
Caskey CT: Overexpression of M68/DcR3 in human gastrointestinal
tract tumors independent of gene amplification and its location in
a four-gene cluster. Proc Natl Acad Sci USA. 97:1230–1235. 2000.
View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Yang CR, Wang JH, Hsieh SL, Wang SM, Hsu
TL and Lin WW: Decoy receptor 3 (DcR3) induces osteoclast formation
from monocyte/macrophage lineage precursor cells. Cell Death
Differ. 11(Suppl 1): S97–S107. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Hsu MJ, Lin WW, Tsao WC, Chang YC, Hsu TL,
Chiu AW, Chio CC and Hsieh SL: Enhanced adhesion of monocytes via
reverse signaling triggered by decoy receptor 3. Exp Cell Res.
292:241–251. 2004. View Article : Google Scholar
|
|
11
|
Tateishi K, Miura Y, Hayashi S, Takahashi
M and Kurosaka M: DcR3 protects THP-1 macrophages from apoptosis by
increasing integrin alpha4. Biochem Biophys Res Commun.
389:593–598. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Shi G, Wu Y, Zhang J and Wu J: Death decoy
receptor TR6/DcR3 inhibits T cell chemotaxis in vitro and in vivo.
J Immunol. 171:3407–3414. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Tsuji S, Hosotani R, Yonehara S, Masui T,
Tulachan SS, Nakajima S, Kobayashi H, Koizumi M, Toyoda E, Ito D,
et al: Endogenous decoy receptor 3 blocks the growth inhibition
signals mediated by Fas ligand in human pancreatic adenocarcinoma.
Int J Cancer. 106:17–25. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Yu KY, Kwon B, Ni J, Zhai Y, Ebner R and
Kwon BS: A newly identified member of tumor necrosis factor
receptor superfamily (TR6) suppresses LIGHT-mediated apoptosis. J
Biol Chem. 274:13733–13736. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Migone TS, Zhang J, Luo X, Zhuang L, Chen
C, Hu B, Hong JS, Perry JW, Chen SF, Zhou JX, et al: TL1A is a
TNF-like ligand for DR3 and TR6/DcR3 and functions as a T cell
costimulator. Immunity. 16:479–492. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Takahashi M, Miura Y, Hayashi S, Tateishi
K, Fukuda K and Kurosaka M: DcR3-TL1A signalling inhibits
cytokine-induced proliferation of rheumatoid synovial fibroblasts.
Int J Mol Med. 28:423–427. 2011.PubMed/NCBI
|
|
17
|
Fukuda K, Miura Y, Maeda T, Takahashi M,
Hayashi S and Kurosaka M: Decoy receptor 3 regulates the expression
of various genes in rheumatoid arthritis synovial fibroblasts. Int
J Mol Med. 32:910–916. 2013.PubMed/NCBI
|
|
18
|
Ducy P and Karsenty G: The two faces of
serotonin in bone biology. J Cell Biol. 191:7–13. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Yadav VK and Ducy P: Lrp5 and bone
formation: A serotonin-dependent pathway. Ann NY Acad Sci.
1192:103–109. 2010. View Article : Google Scholar
|
|
20
|
Voog O, Alstergren P, Leibur E, Kallikorm
R and Kopp S: Immediate effects of the serotonin antagonist
granisetron on temporomandibular joint pain in patients with
systemic inflammatory disorders. Life Sci. 68:591–602. 2000.
View Article : Google Scholar
|
|
21
|
Arnett FC, Edworthy SM, Bloch DA, McShane
DJ, Fries JF, Cooper NS, Healey LA, Kaplan SR, Liang MH, Luthra HS,
et al: The American Rheumatism Association 1987 revised criteria
for the classification of rheumatoid arthritis. Arthritis Rheum.
31:315–324. 1988. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Lovenberg W, Jequier E and Sjoerdsma A:
Tryptophan hydroxylation: Measurement in pineal gland, brainstem,
and carcinoid tumor. Science. 155:217–219. 1967. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Geba GP, Ptak W, Anderson GM, Paliwal V,
Ratzlaff RE, Levin J and Askenase PW: Delayed-type hypersensitivity
in mast cell-deficient mice: Dependence on platelets for expression
of contact sensitivity. J Immunol. 157:557–565. 1996.PubMed/NCBI
|
|
24
|
Walther DJ and Bader M: A unique central
tryptophan hydroxylase isoform. Biochem Pharmacol. 66:1673–1680.
2003. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Karsenty G and Yadav VK: Regulation of
bone mass by serotonin: Molecular biology and therapeutic
implications. Annu Rev Med. 62:323–331. 2011. View Article : Google Scholar
|
|
26
|
Gustafsson BI, Thommesen L, Stunes AK,
Tommeras K, Westbroek I, Waldum HL, Slørdahl K, Tamburstuen MV,
Reseland JE and Syversen U: Serotonin and fluoxetine modulate bone
cell function in vitro. J Cell Biochem. 98:139–151. 2006.
View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Hayashi S, Miura Y, Tateishi K, Takahashi
M and Kurosaka M: Decoy receptor 3 is highly expressed in patients
with rheumatoid arthritis. Mod Rheumatol. 20:63–68. 2010.
View Article : Google Scholar
|
